eWeLL Tops FY2025 Forecasts and Sets Stage for New Medium-Term Growth Plan

eWeLL Co.,Ltd ( (JP:5038) ) has provided an update.

eWeLL Co., Ltd. reported strong FY12/2025 results, with net sales rising 31.9% year on year to ¥3.392 billion and operating profit climbing 35.3% to ¥1.537 billion, delivering a 45.3% operating margin and slightly exceeding its earnings forecasts. Contract numbers increased 15.6% and monthly churn remained extremely low at 0.17%, while a modest decline in unit price per customer reflected a strategic deferral of billing for its AI home-visit scheduling and routes service, which was largely offset by robust performance in its BPaaS and AI plans and reports offerings.

eWeLL signaled a transition to a new medium-term business plan starting next fiscal year that prioritizes future-focused investment alongside continued profit growth. The combination of above-forecast earnings, high-margin operations, and low churn underpins its capacity to fund this next phase of expansion, reinforcing its positioning in the healthcare technology niche and offering stakeholders a picture of sustainable, subscription-driven growth despite short-term revenue timing adjustments.

The most recent analyst rating on (JP:5038) stock is a Hold with a Yen2395.00 price target. To see the full list of analyst forecasts on eWeLL Co.,Ltd stock, see the JP:5038 Stock Forecast page.

More about eWeLL Co.,Ltd

eWeLL Co., Ltd., listed on the Tokyo Stock Exchange Growth Market, operates in the digital healthcare and medical services support sector. The company focuses on subscription-style solutions such as AI-driven home-visit scheduling and routing, BPaaS offerings, and AI-based planning and reporting tools aimed at improving efficiency for healthcare providers and related service organizations.

Average Trading Volume: 74,103

Technical Sentiment Signal: Hold

Current Market Cap: Yen30.53B

For an in-depth examination of 5038 stock, go to TipRanks’ Overview page.